CHMP Recommends Sanofi's Tezeild for EU Approval in Stage 2 Type 1 Diabetes
The CHMP has backed EU approval for Sanofi’s Tezeild, supported by TN-10 study results showing the therapy can delay progression to stage 3 type 1 diabetes in patients with stage 2 disease. If authorised, Tezeild would become the first disease-modifying treatment for T1D in the EU.
Type 1 Diabetes | 15/11/2025 | By Dineshwori | 242
Modular Medical Completes MODD1 Clinical Study, Advances Toward Next-Gen Pivot Pump Launch
US-based insulin delivery technology company Modular Medical has announced the successful completion of a clinical study with its MODD1 pump.
Type 1 Diabetes | 12/09/2025 | By Dineshwori | 209
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy